Key Findings:  Perillyl alcohol demonstrates sufficient neuroprotective activity to provide new avenues in therapy of Parkinson's Disease and its apparent target being restoration of MMP can lead to better understanding of the disease.
Type of Study:  Laboratory Study
Study Result:  Positive
Research Location(s):  India
Year of Pub:  2018
Cannabinoids Studied: 
Phytocannabinoid Source:  Not Applicable
Terpenes Studied:  Limonene
Route of Administration:  In vitro
Citation:  Anis E, et al. Evaluation of phytomedicinal potential of perillyl alcohol in an in vitro Parkinson's Disease model. Drug Dev Res. 2018; 79:218-224. doi: 10.1002/ddr.21436
Authors:  Anis E, Zafeer MF, Firdaus F, Islam SN, Fatima M, Mobarak Hossain M